C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects

Journal of Applied Genetics

Volumn 50, Issue 1, 2009, Pages 63-67

  Goracy, I ^a   Cyrylowski L ^a   Kaczmarczyk, M ^a   Fabian, A ^a   Koziarska, D ^a   Goracy, J ^a   Ciechanowicz, A ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Gene polymorphism; Homocysteine; Ischemic stroke; Methylenetetrahydrofolate reductase; MTHFR gene; Risk factor

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALLELE; ARTICLE; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; ISCHEMIA; MALE; POLAND; RISK; RISK FACTOR; SEX DIFFERENCE; STROKE;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; ISCHEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLAND; POLYMORPHISM, GENETIC; RISK; RISK FACTORS; SEX FACTORS; STROKE;

EID: 63049089113     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03195654     Document Type: Article

References (28)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al.1993. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST:Trial ofOrg10172 in Acute Stroke Treatment. Stroke 24: 35-41.
2. Alluri RV, Mohan V, Komandur S, Chawda K, Chaudhuri JR, Hasan Q, 2005. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 12: 40-44.
3. Boushey C, Beresford S, Omenn G, Motulsky A, 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057.
4. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L, 1998. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98: 2520-2526.
5. Casas JP, Hingorani AD, Bautista LE, Sharma P, 2004. Meta-analysis of genetic studies in ischemic stroke. Thirty-two genes involving approximately 18000 cases and 58000 controls. Arch Neurol 61: 1652-1661.
6. Dikmen M, Ozbabalik D, Gunes HV, Degirmenci I, Bal C, Ozdemir G, et al. 2006. Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol Scand 113: 307-314.
7. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI, 2000. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31: 1069-1071.
8. Freiberger T, Vyskocilova M, Kolarova L, Kuklinek P, Krystufkova O, Lahodna M, et al. 2002. Exon 1 polymorphismof the B2BKR gene does not influence the clinical status of patientswith hereditary angioedema. Hum Immunol 63: 492-494.
9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
10. Kalita J, Srivastava R, Bansal V, Agarwal S, Misra UK, 2006. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients. Neurol India 54: 260-263.
11. Kohara K, Fujisawa M, Ando F, Tabara Y, Niino N, Miki T, et al. 2003. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population. The NILS-LSA Study. Stroke 34: 1130-1135.
12. Kostulas K, Crisby M, Huang WX, Lannfelt L, Hagenfeldt L, Eggertsen G, et al. 1998. A methylenetetrahydrofolate reductase gene polymorphism in ischemic stroke and in carotid artery stenosis. Eur J Clin Invest 28: 285-289.
13. Kristensen B, Malm J, Nilsson N, Hultdin J, Carlberg B, Dahlen G, et al. 1999. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 30: 974-980.
14. Lahiri DK, Bye S, Nurnberger Jr. JI, Hodes ME, Crisp M, 1992. A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Bioph Meth 25: 193-205.
15. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, et al. 2003. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke. A multicenter case-control study in China. Stroke 34: 2085-2090.
16. Linnebank M, Montenarh M, Kölsch H, Linnebank A, Schnez K, Schweichel D, et al. 2005. Common genetic variants of homocysteine metabolism in ischemic stroke: a case-control study. Eur J Neurol 12: 614-618.
17. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J, 1997. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28: 1739-1743.
18. Miller SP, Wu YW, Lee J, Lammer EJ, Iovannisci DM, Glidden DV, et al. 2006. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke 37: 2678-2683.
19. Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kiruhara Y, et al. 1998. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscl Throm Vas Biol 18: 1465-1469.
20. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. 1997. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95: 2032-2036.
21. Morizane M, Yoshida S, Nakago S, Hamana S, Maruo T, Kennedy S, 2004. No association of endometriosis with glutathione S-transferase M1 and T1 null mutations in a Japanese population. J Soc Gynecol Invest 11: 118-121.
22. Moskvina V, Holmans P, Schmidt K, Craddock N, 2005. Design of case-controls studies with unscreened controls. Ann Hum Genet 69: 566-576.
23. Pezzini A, del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, et al. 2002. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33: 664-669.
24. Schürks M, Zee R, Buring J, Kurth T, 2008. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 71: 505-513.
25. Soriente L, Coppola A, Madonna P, Cerbone AM, Di Minno G, Orefice G, et al. 1998. Homozygous C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke. Stroke 29: 869 - 871.
26. Szolnoki Z, Havasi V, Bene J, Komlosi K, Szoke D, Somogyvari F, et al. 2005. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol Scand 111: 29-33.
27. Szolnoki Z, Melegh B, 2006. Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis. Curr Med Chem 13: 1627-1634.
28. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bene J, et al. 2004. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurol Scand 109: 222-227.